INTEGRATION
Built to sit alongside the systems you already use.
PharmAlert is not a replacement for your prescribing or pharmacy system. It is a checking layer that connects to it — through an API, an embedded component, or batch review.
Integration surfaces
- REST API
- Send a patient and a medicine list, receive prioritised findings. Stateless, no patient data retained.
- EMBEDDED COMPONENT
- A drop-in panel that renders inside your existing prescribing interface.
- BATCH REVIEW
- Run checks across a caseload for structured medication review and population-level reporting.
Request and response
POST /v1/check
{
"patient": {
"age": 74,
"sex": "F",
"eGFR": 42,
"hepatic": "normal",
"pregnant": false,
"allergies": [
"penicillin"
],
"conditions": []
},
"medicines": [
{
"id": "metformin",
"dose": 1,
"unit": "g",
"frequency": "BD"
},
{
"id": "apixaban",
"dose": 5,
"unit": "mg",
"frequency": "BD"
},
{
"id": "ibuprofen",
"dose": 400,
"unit": "mg",
"frequency": "TDS"
}
]
}{
"evaluated": 36,
"alerts": [
{
"id": "PA-DOS-003",
"severity": "warning",
"category": "dose",
"title": "Metformin · eGFR 30–44",
"reason": "At this level of renal function the maximum metformin dose is reduced, typically to 1 g daily in divided doses.",
"evidence": "Well documented · Established",
"suggestion": "Reduce the dose and review renal function every three to six months — confirm against local guidance.",
"score": 90,
"rank": 1
},
{
"id": "PA-DOS-012",
"severity": "warning",
"category": "dose",
"title": "Apixaban · eGFR 30–59",
"reason": "Moderate renal impairment raises apixaban exposure. The dose remains standard for most patients, but renal function needs to be tracked rather than assumed stable.",
"evidence": "Well documented · Established",
"suggestion": "Review renal function at least every six months, and reassess the dose if eGFR falls further.",
"score": 90,
"rank": 2
},
{
"id": "PA-INT-022",
"severity": "warning",
"category": "interaction",
"title": "Anticoagulant + NSAID",
"reason": "Additive bleeding risk through separate mechanisms — anticoagulation plus mucosal injury and platelet effect.",
"evidence": "Well documented · Established",
"suggestion": "Paracetamol or a topical NSAID. If an oral NSAID is essential, add gastroprotection and review the indication.",
"score": 90,
"rank": 3
}
]
}Generated by the same checking logic that runs the demonstration on this site. Fictional patient.
Standards
We work with FHIR, SNOMED CT and dm+d. Where support is planned rather than available, it is labelled as planned on this page.
| Requirement | Status |
|---|---|
| FHIR R4 | Supported |
| SNOMED CT | Supported |
| dm+d | Supported |
| HL7 v2 | Planned |
Implementation
A typical technical integration takes four to eight weeks, depending on your environment and information governance process. We will give you an honest estimate for your setting before you commit to anything.
Tell us what you are running.
We will give you an honest estimate for your environment before you commit to anything.
Talk to the technical team